Home » Topics » Regulatory » Patents

Patents
RSS

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

May 10, 1999

Naturally occurring terpene with immunosuppressive and neovascularization-inhibitory effects

May 10, 1999

New antiinflammatory/analgesic agents with both topical and oral activity

May 10, 1999

Sankyo's new antibiotics described in patent literature

May 10, 1999

Potent, orally active antiulcer agents synthesized at SS Pharm.

May 10, 1999

Yamanouchi describes novel series of factor Xa inhibitors

May 10, 1999

New prostaglandin F analogues from P&G targeted for bone disorders, glaucoma

May 7, 1999

Substituted morpholines as tachykinin antagonists, 5-HT agonists

May 7, 1999

Clarion discloses new wound-healing agents in development

May 7, 1999

BE-55051: novel antitumor substance produced by Streptomyces

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...